Testosterone testing in the United States: limited price transparency and significant variability
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Nearly half of US hospitals fail to report testosterone test prices, despite federal regulations. This lack of transparency leads to significant price variations and hinders informed consumer choices for essential lab tests.
Area Of Science
- Health economics
- Clinical laboratory science
- Healthcare policy
Background
- The Centers for Medicare & Medicaid Services (CMS) mandated hospital price transparency in 2021.
- Understanding hospital price reporting for common diagnostic tests is crucial for patient access and cost awareness.
- Testosterone testing is a common diagnostic procedure with variable pricing.
Purpose Of The Study
- To evaluate hospital-reported price transparency and price variability for testosterone (T) testing across the US.
- To identify factors influencing hospital price reporting for T tests.
- To assess the impact of the 2021 CMS regulation on T test price disclosure.
Main Methods
- Analysis of the Turquoise database to identify hospitals reporting prices for free or total T tests.
- Comparison of hospital characteristics between price reporters and non-reporters.
- Multivariable regression to determine predictors of reporting and assess price variability by test and payer type.
Main Results
- 51.7% of 6700 US hospitals reported at least one T test price.
- Price reporting was more common in larger, non-profit hospitals and those with higher compliance scores.
- Significant regional price variation was observed, with median prices for total T at $84.90 and free T at $92.27, differing by payer.
Conclusions
- Despite the 2021 regulation, a substantial number of hospitals do not report T test prices.
- Price reporting is associated with hospital size and ownership type.
- Lack of price transparency contributes to significant price variation and limits consumer choice for T testing.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
A complete procedure to test a claim about population standard deviation or population variance is explained here.
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...